Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinone

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 22, 2003, Pages 4749-4759

  Fossa, Paola ^a   Menozzi, Giulia ^a   Dorigo, Paola ^b   Floreani, Maura ^b   Mosti, Luisa ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1H INDENO[1,2 B]PYRIDINE 2,5 DIONE; 2 PYRIDONE DERIVATIVE; 5 PROPIONYL 6 ETHYL 1,2 DIHYDRO 2 OXOPYRIDINE 3 CARBOXYLIC ACID; 6 ETHYL 5 PROPIONYLPYRIDIN 2(1H) ONE; ACETIC ACID DERIVATIVE; CARDIOTONIC AGENT; METHYL 1,2,5,6,7,8 HEXAHYDRO 2,5 DIOXOQUINOLINE 3 CARBOXYLATE; METHYL 2,5 DIHYDRO 2,5 DIOXO 1H INDENO[1,2 B]PYRIDINE 3 CARBOXYLATE; METHYL 2,5 DIHYDRO 2,5 DIOXO 1H [1]PYRIDINE 3 CARBOXYLATE; METHYL 5 ACETYL 6 METHYL 1,2 DIHYDRO 2 OXOPYRIDINE 3 CARBOXYLATE; METHYL 5 BENZOYL 6 PHENYL 1,2 DIHYDRO 2 OXOPYRIDINE 3 CARBOXYLATE; METHYL 5 ISOBUTYRYL 6 ISOPROPYL 1,2 DIHYDRO 2 OXOPYRIDINE 3 CARBOXYLATE; METHYL 5 PROPIONYL 6 ETHYL 1,2 DIHYDRO 2 OXOPYRIDINE 3 CARBOXYLATE; METHYL 7 METHYL 1,2,5,6,7,8 HEXAHYDRO 2,5 DIOXOQUINOLINE 3 CARBOXYLATE; METHYL 7 PHENYL 1,2,5,6,7,8 HEXAHYDRO 2,5 DIOXOQUINOLINE 3 CARBOXYLATE; METHYL 7,7 DIMETHYL 1,2,5,6,7,8 HEXAHYDRO 2,5 DIOXOQUINOLINE 3 CARBOXYLATE; METHYLCYANOACETATE; MILRINONE; PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; HEART ATRIUM CONTRACTILITY; HEART MUSCLE; MALE; NONHUMAN;

CAVIA PORCELLUS; SUS SCROFA;

EID: 0141992308     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00528-5     Document Type: Article

References (34)

1. Farah A.E., Alousi A.A. Life Sci. 22:1978;1139.
2. Nicholson C.D., Challiss R.A.J., Shahid M. Trends Pharmacol. Sci. 12:1991;19.
3. Kikura M., Levy J.H. Int. Anestesiol. Clin. 33:1995;21.
4. Kishi T., Nakahashi K., Ito H., Taniguchi S., Takaki M. Clin. Exp. Pharmacol. Physiol. 28:2001;737.
5. Moos W.H., Humblet C.C., Sircar I., Rithner C., Weishaar R.E., Bristol J.A., McPhail A.T. J. Med. Chem. 30:1987;1963.
6. Dorigo P., Maragno I. Br. J. Pharm. 87:1986;623.
7. Mosti L., Schenone P., Menozzi G. J. Heterocyclic Chem. 22:1985;1503.
8. Lo Presti E., Boggia R., Feltrin A., Menozzi G., Dorigo P., Mosti L. Il Farmaco. 54:1999;465.
9. Dorigo P., Gaion R.M., Belluco P., Fraccarollo D., Maragno I., Bombieri G., Benetollo F., Mosti L., Orsini F. J. Med. Chem. 36:1993;2475.
10. Dorigo P., Gaion R.M., Belluco P., Borea P.A., Guerra L., Mosti L., Floreani M., Carpenedo F. Gen. Pharmacol. 23:1992;535.
11. Fossa P., Giordanetto F., Menozzi G., Mosti L. Quant. Struct. Act. Relat. 21:2002;267.
12. (a) Boggia R., Forina M., Fossa P., Mosti L. Quant. Struct. Act. Relat. 16:1997;201
13. (b) Altomare C., Cellamare S., Summo L., Fossa P., Mosti L., Carotti A. Bioorg. Med. Chem. 8:2000;909.
14. Hidaka H., Endo T. Adv. Cyclic Nucleotide Protein Phosphoryl. Res. 16:1984;245.
15. Giordanetto F., Fossa P., Menozzi G., Schenone S., Bondavalli F., Ranise A., Mosti L. J. Comput. Aided Mol. Des. 17:2003;39.
16. Schenone P., Mosti L., Menozzi G. J. Heterocyclic Chem. 19:1982;1355.
17. Baker S.R., Cromble L., Dove R.V., Slack D.A. J. Chem. Soc. Perkin Trans. 1. 1979;677.
18. Endoh M. Jpn. J. Pharmacol. 29:1979;855.
19. Endoh M. J. Cardiovasc. Pharmacol. 40:2002;323.
20. Floreani M., Fossa P., Gessi S., Mosti L., Borea P.A., Dorigo P. Naunyn-Schmiedeberg's Arch. Pharmacol. 367:2003;109.
21. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.
22. Alousi A.A., Canter J.M., Montanaro M.J., Fort D.J., Ferrari R.A. J. Cardiovasc. Pharmacol. 5:1983;792.
23. Keef K.D., Hume J.R., Zhong J. Am. J. Physiol. Cell Physiol. 281:2001;C1743.
24. Zhang W., Ke H., Tretiakova A.P., Jameson B., Colman R.W. Protein Sci. 10:2001;1481, and references cited therein.
25. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.-N., Linden J. Pharmacol. Rev. 53:2001;527.
26. Weishaar R.E., Burrows S.D., Kobylarz D.C., Quade M.M., Evans D.B. Biochem. Pharmacol. 35:1986;787.
27. Lowry O.H., Rosebrough N.J., Farra A.L., Randall R.L. J. Biol. Chem. 193:1951;265.
28. Thompson W.J., Brooker G., Appleman M.M. Meth. Enzymol. 38:1974;205.
29. Slaughter R.S., Sutko J.L., Reeves J.P. J. Biol. Chem. 258:1983;3183.
30. Floreani M., Forlin A., Pandolfo L., Petrone M., Bellin S. J. Pharmacol. Exp. Ther. 278:1996;763.
31. Jones L.R., Besch H.R. Jr., Watanabe A.M. J. Biol. Chem. 252:1977;3315.
32. Floreani M., Santi Soncin E., Carpenedo F. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;448.
33. MacroModel version 7.0, Schrödinger LLC. Mohamadi, F. Richards N.G.J., Guida W.C., Liskamp R., Lipton M., Caufield C., Chang G., Hendrickson T., Still W.C. J. Comput. Chem. 11:1990;440.
34. Spartan 'O2; Wavefunction Inc.: Irvine, CA, USA.